Literature DB >> 8891797

N-alkylvaline levels in globin as a new type of biomarker in risk assessment of alkylating agents.

J Lewalter1.   

Abstract

Adducts with the N-terminal valine of erythrocyte globin can serve as individual biomarkers of systemic and cellular exposure to endogenous and exogenous alkylating agents. In contrast to "detoxification markers" of this kind of mecapturic acids derived from alkylation of glutathione, individual N-alkylations of valine in globin reflect the formally "toxifying" part of the stress due to alkylating agents transformed into the ultimate toxicant. Thus, in contrast to the traditional methods of biological monitoring this approach enables a better evaluation of systemic exposure to reactive agents, adapted more sensibly to the exposure situation over the whole life span of erythrocytes, and it can serve as a specific biomarker of exposure for the purpose of health surveillance in occupational medicine. An individual evaluation of exposures in comparison with the range of corresponding background levels is discussed from the point of view of supplementary risk assessment in medical surveillance of occupationally exposed persons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891797     DOI: 10.1007/bf00377881

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  21 in total

Review 1.  Protein adducts in the molecular dosimetry of chemical carcinogens.

Authors:  P L Skipper; S R Tannenbaum
Journal:  Carcinogenesis       Date:  1990-04       Impact factor: 4.944

2.  Levels of benzene and other volatile aromatic compounds in the blood of non-smokers and smokers.

Authors:  H Hajimiragha; U Ewers; A Brockhaus; A Boettger
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

3.  Analysis, storage stability and reference values for urinary chromium and nickel.

Authors:  M Kiilunen; J Järvisalo; O Mäkitie; A Aitio
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

4.  Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin.

Authors:  M Törnqvist; S Osterman-Golkar; A Kautiainen; S Jensen; P B Farmer; L Ehrenberg
Journal:  Carcinogenesis       Date:  1986-09       Impact factor: 4.944

Review 5.  The significance of DNA and protein adducts in human biomonitoring studies.

Authors:  F P Perera
Journal:  Mutat Res       Date:  1988 May-Aug       Impact factor: 2.433

6.  Methylations in human hemoglobin.

Authors:  M Törnqvist; S Osterman-Golkar; A Kautiainen; M Näslund; C J Calleman; L Ehrenberg
Journal:  Mutat Res       Date:  1988-03       Impact factor: 2.433

7.  Urinary t,t-muconic acid as an indicator of exposure to benzene.

Authors:  O Inoue; K Seiji; H Nakatsuka; T Watanabe; S N Yin; G L Li; S X Cai; C Jin; M Ikeda
Journal:  Br J Ind Med       Date:  1989-02

8.  Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method.

Authors:  M Törnqvist; J Mowrer; S Jensen; L Ehrenberg
Journal:  Anal Biochem       Date:  1986-04       Impact factor: 3.365

9.  In vivo formation and persistence of modified nucleosides resulting from alkylating agents.

Authors:  B Singer
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

Review 10.  Markers of exposure to carcinogens.

Authors:  G N Wogan
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

View more
  3 in total

1.  Dimethyl sulphate; a hidden problem in occupational medicine.

Authors:  T Schettgen; H C Broding; J Angerer; H Drexler
Journal:  Occup Environ Med       Date:  2004-01       Impact factor: 4.402

2.  Simultaneous quantification of eight hemoglobin adducts of genotoxic substances by isotope-dilution UHPLC-MS/MS.

Authors:  Fabian Gauch; Klaus Abraham; Bernhard H Monien
Journal:  Anal Bioanal Chem       Date:  2022-06-02       Impact factor: 4.478

3.  Identification of biomarkers specific to five different nicotine product user groups: Study protocol of a controlled clinical trial.

Authors:  Filip Sibul; Therese Burkhardt; Alpeshkumar Kachhadia; Fabian Pilz; Gerhard Scherer; Max Scherer; Nikola Pluym
Journal:  Contemp Clin Trials Commun       Date:  2021-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.